{"title":"肿瘤糖基化变化作为治疗靶点:机遇与挑战","authors":"Lu-Gang Yu","doi":"10.4172/2168-958X.S1-E001","DOIUrl":null,"url":null,"abstract":"Copyright: © 2013 Yu LG. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Alterations in cell surface glycosylation are common features in cancer. Many of these glycosylation changes result in expression of cancer-associated carbohydrate antigens such as Tn (GalNAcαSer/Thr), sialyl-Tn (sialic acid-β1,6GalNAcα-Ser/Thr), TF(Galβ1,3 GalNAcα-Ser/Thr) and Lewis-related carbohydrate structures. These glycosylation changes have offered multiple opportunities for potential therapeutic treatment of cancer.","PeriodicalId":92404,"journal":{"name":"Journal of glycobiology","volume":"2013 1","pages":"1-2"},"PeriodicalIF":0.0000,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4172/2168-958X.S1-E001","citationCount":"1","resultStr":"{\"title\":\"Glycosylation Change in Cancer as Therapeutic Target: Opportunities and Challenges\",\"authors\":\"Lu-Gang Yu\",\"doi\":\"10.4172/2168-958X.S1-E001\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Copyright: © 2013 Yu LG. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Alterations in cell surface glycosylation are common features in cancer. Many of these glycosylation changes result in expression of cancer-associated carbohydrate antigens such as Tn (GalNAcαSer/Thr), sialyl-Tn (sialic acid-β1,6GalNAcα-Ser/Thr), TF(Galβ1,3 GalNAcα-Ser/Thr) and Lewis-related carbohydrate structures. These glycosylation changes have offered multiple opportunities for potential therapeutic treatment of cancer.\",\"PeriodicalId\":92404,\"journal\":{\"name\":\"Journal of glycobiology\",\"volume\":\"2013 1\",\"pages\":\"1-2\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2016-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.4172/2168-958X.S1-E001\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of glycobiology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4172/2168-958X.S1-E001\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of glycobiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4172/2168-958X.S1-E001","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
Glycosylation Change in Cancer as Therapeutic Target: Opportunities and Challenges
Copyright: © 2013 Yu LG. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Alterations in cell surface glycosylation are common features in cancer. Many of these glycosylation changes result in expression of cancer-associated carbohydrate antigens such as Tn (GalNAcαSer/Thr), sialyl-Tn (sialic acid-β1,6GalNAcα-Ser/Thr), TF(Galβ1,3 GalNAcα-Ser/Thr) and Lewis-related carbohydrate structures. These glycosylation changes have offered multiple opportunities for potential therapeutic treatment of cancer.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
